REIMIBURSEMENT UNRAVELLED: Will new French medtech innovation plans hit the spot?
This article was originally published in Clinica
Executive Summary
Securing reimbursement for innovative medical devices in France calls for high levels of human and financial input. Yet the often cumbersome and misfiring adoption procedures deter manufacturers from approaching this ostensibly attractive medical device market – Europe’s second largest. But Corinne Lebourgeois* explains that a revamped “forfait innovation” might provide the much-needed change